The Angeles Clinic and Research Institute — Los Angeles, California

Public research footprint of The Angeles Clinic and Research Institute, compiled from the ClinicalTrials.gov public registry.

135

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Advanced Solid Tumors · Non-Small Cell Lung Cancer · Melanoma · Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8

Recently updated registry entries

NCT06058377 — Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment… (Recruiting)
NCT05564377 — Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced… (Recruiting)
NCT06568172 — Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the… (Suspended)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Angeles Clinic and Research Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.